eHealth, Inc. (EHTH) · Oct 16, 2026 · Delisting
Nasdaq deficiency notice — Below $1 minimum bid price for 30 consecutive business days; cure deadline April 12, 2027
eHealth received a Nasdaq delisting warning after 30 trading days below $1, giving it until April 12, 2027 to regain compliance.
eHealth is navigating a Medicare-heavy business transition, not reporting a new operating result. Its strategy centers on reducing off-season marketing, deepening relationships with existing members, and expanding its insurance-advisory model; second-quarter revenue fell 45% year over year as part of that reset. The filing adds a separate capital-markets problem: Nasdaq says the stock closed below its $1 minimum bid requirement for 30 consecutive business days.
This is a warning, not an immediate delisting. Trading continues on Nasdaq, and the company has 180 calendar days—through April 12, 2027—to produce a closing bid of at least $1 for 10 consecutive business days. 〔0〕 〔1〕
The main complication is that the likely fix could dilute or disrupt shareholders. eHealth says it may seek approval for a reverse stock split if needed, while a second 180-day period would require meeting eligibility rules and potentially moving to Nasdaq’s Capital Market. 〔2〕 That makes the notice more than administrative: it introduces a future financing, governance, and listing-risk overhang while the company is already trying to rebuild growth around Medicare member value.
Bottom line: This filing does not change eHealth’s operating plan, but it adds a genuine Nasdaq-compliance problem and a possible reverse-split decision. The risk is manageable for now, yet clearly negative because the company must repair its share price before April 12, 2027 to avoid escalating listing consequences.
Regain $1 bid price by April 12, 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!